Paracetamol-associated knowledge, attitudes and practices of the New Zealand public: an online survey
Samantha Marsh
1
2
3
4
Abstract
Although paracetamol is the most widely used prescription and over-the-counter drug globally, it also has a higher toxicity than other common non-opioid analgesics and is a leading preventable cause of acute liver failure and liver transplants. International evidence suggests that the public may have inadequate knowledge about paracetamol; however, in Aotearoa New Zealand (NZ), paracetamol is relatively cheap and readily available in large quantities at pharmacy and non-pharmacy outlets.
To identify paracetamol-associated knowledge, attitudes and beliefs of the NZ public.
Using Horizon Research Limited, a NZ-based research panel, we explored paracetamol-associated knowledge, attitudes and practices using an online survey.
A total of 1723 respondents completed the survey. High rates of unintentional misuse of paracetamol were identified, in addition to significant knowledge gaps, particularly those related to participants’ ability to identify paracetamol-containing formulations. Participants were also supportive of introducing policies restricting the supply and sale of paracetamol, such as where paracetamol can be purchased.
There appears to be a need to increase the NZ public’s knowledge of the safe use of paracetamol. Given the current lack of policies restricting access to paracetamol, the substantial proportion of the NZ adult population exceeding paracetamol dosing guidelines, and the public’s apparent support for introducing policies, our findings may have important implications. However, research is required to understand the potential impact of tightening current regulatory policies, including restricting where you can purchase paracetamol or reducing the amount of paracetamol you can purchase at once, before they are introduced.
Keywords: attitudes, consumer knowledge, harm reduction, health policy, medication misuse, medication safety, paracetamol, public health.
References
1 Prescott LF. Paracetamol: past, present, and future. Am J Ther 2000; 7(2): 143-7.
| Google Scholar | PubMed |
2 World Health Organization. WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents; 2018. Available at https://www.who.int/publications/i/item/9789241550390
3 Abdel Shaheed C, Ferreira GE, Dmitritchenko A, et al. The efficacy and safety of paracetamol for pain relief: an overview of systematic reviews. Med J Aust 2021; 214(7): 324-31.
| Crossref | Google Scholar | PubMed |
4 Liew Z, Ritz B, Rebordosa C, et al. Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders. JAMA Pediatr 2014; 168(4): 313-20.
| Crossref | Google Scholar | PubMed |
5 Moore N, Ganse EV, Parc J-ML, et al. The PAIN study: Paracetamol, Aspirin and Ibuprofen New tolerability study: a large-scale, randomised clinical trial comparing the tolerability of aspirin, ibuprofen and paracetamol for short-term analgesia. Clin Drug Investig 1999; 18: 89-98.
| Crossref | Google Scholar |
6 Wang X, Wu Q, Liu A, et al. Paracetamol: overdose-induced oxidative stress toxicity, metabolism, and protective effects of various compounds in vivo and in vitro. Drug Metab Rev 2017; 49(4): 395-437.
| Crossref | Google Scholar | PubMed |
7 Ferner RE, Dear JW, Bateman DN. Management of paracetamol poisoning. BMJ 2011; 342: d2218.
| Crossref | Google Scholar | PubMed |
8 Kumpula E-K, Paterson DA, Pomerleau AC. A retrospective analysis of therapeutic drug exposures in New Zealand National Poisons Centre data 2018–2020. Aust N Z J Public Health 2023; 47(2): 100027.
| Crossref | Google Scholar | PubMed |
9 PHARMAC. Paracetamol Community Schedule; 2023. Available at https://schedule.pharmac.govt.nz/ScheduleOnline.php?edition=&osq=Paracetamol
10 Kumpula E-K, Norris P, Pomerleau AC. Stocks of paracetamol products stored in urban New Zealand households: a cross-sectional study. PLoS One 2020; 15(6): 0233806.
| Crossref | Google Scholar | PubMed |
11 Bateman DN. Pack size and paracetamol overdose: 16 years later. Clin Toxicol 2014; 52(8): 821-3.
| Crossref | Google Scholar | PubMed |
12 Andersen CU, Hansen S, Dalhoff KP, et al. Clinical characteristics of hospitalized patients with paracetamol poisoning before and after restrictions of over-the-counter sale of paracetamol. Clin Toxicol 2023; 61: 228-33.
| Crossref | Google Scholar |
13 Morgan O, Majeed A. Restricting paracetamol in the United Kingdom to reduce poisoning: a systematic review. J Public Health 2005; 27(1): 12-8.
| Crossref | Google Scholar | PubMed |
14 Hornsby LB, Whitley HP, Hester EK, et al. Survey of patient knowledge related to acetaminophen recognition, dosing, and toxicity. J Am Pharm Assoc 2010; 50(4): 485-9.
| Crossref | Google Scholar | PubMed |
15 Håkonsen H, Hedenrud T. A population‐based study of risk perceptions of paracetamol use among Swedes—with a special focus on young adults. Pharmacoepidemiol Drug Saf 2017; 26(8): 992-7.
| Crossref | Google Scholar | PubMed |
16 Andrade C, Menon V, Ameen S, et al. Designing and conducting knowledge, attitude, and practice surveys in psychiatry: practical guidance. Indian J Psychol Med 2020; 42(5): 478-81.
| Crossref | Google Scholar | PubMed |
18 Horizon Research. Horizon’s online research standards in relation to international best practice guidelines; 2021. Available at https://horizonpoll.co.nz/attachments/docs/horizon-research-methodology-2021.pdf
20 Saengcharoen W, Buasri N, Khantapokha B, et al. Public knowledge and factors associated with inappropriate analgesic use: a survey in Thailand. Int J Pharm Pract 2016; 24(1): 22-9.
| Crossref | Google Scholar | PubMed |
21 Wood DM, English E, Butt S, et al. Patient knowledge of the paracetamol content of over-the-counter (OTC) analgesics, cough/cold remedies and prescription medications. Emerg Med J 2010; 27(11): 829-33.
| Crossref | Google Scholar | PubMed |
22 Fosnocht D, Taylor JR, Caravati EM. Emergency department patient knowledge concerning acetaminophen (paracetamol) in over-the-counter and prescription analgesics. Emerg Med J 2008; 25(4): 213-6.
| Crossref | Google Scholar | PubMed |
23 Kaufman DW, Kelly JP, Rohay JM, et al. Prevalence and correlates of exceeding the labeled maximum dose of acetaminophen among adults in a US‐based internet survey. Pharmacoepidemiol Drug Saf 2012; 21(12): 1280-8.
| Crossref | Google Scholar | PubMed |
24 Pape E, Collin C, Camelot F, et al. Paracetamol misuse and dental pain: results from the French observational DAntaLor study. J Oral Facial Pain Headache 2019; 33(1): 123-9.
| Crossref | Google Scholar | PubMed |